Results from innovative tuberculosis vaccine trial show potential for new BCG revaccination strategies and hope for subunit vaccines.
Scientists from the South African Tuberculosis Vaccine Initiative (SATVI) based at the University of Cape Town and the Desmond Tutu HIV Foundation have presented the findings of an innovative clinical trial that provides encouraging new evidence that TB vaccines could prevent sustained TB infections in high-risk adolescents. The results were presented at the 5th Global…